Alkermes Announces Approval Of VIVITROL(R) For The Treatment Of Alcohol Dependence In Russia

August 7th, 2008 by admin

Alkermes, Inc. (NASDAQ: ALKS) declared that its partner, Cilag GmbH International, a supplementary of President & Johnson, conventional support from the Slavonic Regulatory Authorities to mart VIVITROL® (naltrexone for extended-release injectable suspension) for the communication of beverage dependency in Russia. The creation module be manufactured by Alkermes and commercial by Janssen-Cilag, an affiliate consort of Cilag GmbH International.

Tags: , , ,

Posted in Addiction |

Related posts

Comments are closed.